Adam Perlman, a nationally recognized first-chair patent trial lawyer, represents clients across a range of technologies. In particular, he represents brand-name pharmaceutical companies in Hatch-Waxman trials and Federal Circuit appeals.
Mr. Perlman regularly serves as lead counsel in major patent litigation matters in district courts throughout the United States as well as before the US Court of Appeals for the Federal Circuit. He also routinely litigates life sciences inter partes review proceedings before the US Patent and Trademark Office (USPTO).
Mr. Perlman has successfully represented some of the world’s leading brand-name pharmaceutical companies in complex ANDA matters, and he has tried 13 Hatch-Waxman cases. Beyond Hatch-Waxman cases, his practice involves a wide range of industries.